Search results
Displaying 1 - 10 of 37 results
-
Safety Signal: Changes to the labelling of Bicillin LA®
Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
-
Pharmac leaflet explaining medicine brand changes
This leaflet from Pharmac explains why brand names, appearance and packaging of your medicines may have changed.
-
Gary's story: a consumer perspective on taking warfarin
This is the story of Gary Edwards, a 60-year-old builder from Waitarere Beach, who ended up on Warfarin after a cardiac event.
-
Opioid implementation package
This package outlines the next steps and what the options are to make a significant difference in opioid-induced adverse drug events.
-
Taking Your Medicine Safely pamphlet
A medication safety pamphlet for patients.
-
Acetylcysteine for the treatment of paracetamol overdose and toxicity – 2-bag dosing guidance
New dosing guidance for acetylcysteine for the treatment of paracetamol overdose and toxicity issued in January 2019.
-
Health literacy medication safety project evaluation report, training tools and resources (August 2013)
Evaluation report and resources from Malatest International and resources from Workbase Education Trust for the Commission's health literacy medication safety demonstration project.
-
Pharmac leaflet on practical tips for giving medicine to kids
This leaflet from Pharmac provides practical tips for giving medicine to babies, toddlers and young children.
-
Safe use of opioids measurement: frequently asked questions
Frequently asked questions about measurement for the safe use of opioids.
-
ALERT 17: Alteplase or tenecteplase?
An alert has been issued to highlight the need to clearly differentiate between stroke thrombolysis and myocardial infarction thrombolysis.